Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Program
-
Field
-
The Department of Molecular Biology, Umeå University, Sweden, seeks a postdoctoral researcher to pursue a project in single cell transcriptomics of microorganisms. The employment is full-time for
-
hubs. Research Areas: Cancer Biology & Oncology Research Cell & Developmental Biology Stem Cell Biology & Regenerative Medicine Computational Neuroscience & Systems Biology Why Join Us? Internationally
-
epigenetics or/and experience in working on embryonic/adult stem cells and cancer cell lines are a plus. The Somyajit lab, based at Department of Biochemistry and Molecular Biology , SDU, has a deep interest in
-
Therapy Financial Counselor is responsible for coordinating all financial phases of Stem Cell Transplant and Immune Effector Cell (IEC) therapy at Dana Farber Cancer Institute and its partner facilities
-
diseases. The successful candidate will work on projects focused on B cell development and differentiation using induced pluripotent stem cell-based system and several cutting-edge technologies CRISPR-based
-
validation of these models using human induced pluripotent stem cells (hiPSCs). In collaboration with members of the OMBION consortium, you will further expand our systems to include relevant pain-associated
-
project exploring the use of engineered biomaterials to examine how extracellular matrix architecture influences stem cell differentiation in the context of osteoarthritis. During this post, the successful
-
for Hematology and Regenerative Medicine (HERM) at the Department of Medicine, Huddinge , is seeking a highly motivated PhD student to use pluripotent stem cells for studying human hematopoiesis and modeling
-
000 individuals in UK. As part of a wider strategy to develop a deep human experimental medicines platform, this project aims to mainly focus on using novel human in vitro platforms using IBD gut stem
-
on research into a rare corneal disease called limbal stem cell deficiency (LSCD), which leads to blindness and currently has no effective treatment options. The research group uses various transgenic and